StockData
Microbot Medical Inc. logo

Microbot Medical Inc. (MBOT) stock

MBOTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$0.64−0.33 (-34.16%)

Close on Nov 16, 2026Market cap $43.28MP/E –Yield –

Microbot Medical profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Microbot Medical's profit margin for the twelve months ending Sep 30, 2016 was 22271.3%. For fiscal 2015 it was -787.9%, against -15345.1% the year before. The highest annual figure on record is -787.9% in fiscal 2015.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2015Dec 31, 2015-787.9%+14557.2
FY2013Dec 31, 2013-15345.1%−13262.4
FY2012Dec 31, 2012-2082.8%−335.5
FY2011Dec 31, 2011-1747.3%+21.7
FY2010Dec 31, 2010-1769.0%+953.0
FY2009Dec 31, 2009-2722.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-2334.9%–
Q1 FY2026Mar 31, 2026-3496.2%–
Q3 FY2016Sep 30, 2016-1990.1%–
Q2 FY2016Jun 30, 2016-559.5%–

More Microbot Medical figures

See a number that looks wrong?